Financhill
Sell
48

CIM Quote, Financials, Valuation and Earnings

Last price:
$12.90
Seasonality move :
-3.07%
Day range:
$12.77 - $12.91
52-week range:
$9.85 - $15.37
Dividend yield:
11.47%
P/E ratio:
9.76x
P/S ratio:
1.27x
P/B ratio:
0.65x
Volume:
360.3K
Avg. volume:
739.3K
1-year change:
-10.23%
Market cap:
$1.1B
Revenue:
$770.2M
EPS (TTM):
-$0.41

Earnings Data

Next earnings date for CIM
Feb 11
2026
Most recent earnings per share
-$0.27
Missed by $0.73
(Nov 6/2025)
Consensus Estimate
$0.46
(Nov 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CIM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/11/2026 Q4 $80.8M -- -- $0.50 --
11/06/2025 Q3 $83.9M $229.8M -$0.27 $0.46 -$0.73
08/06/2025 Q2 $83.4M $198.3M $0.17 $0.46 -$0.29
05/08/2025 Q1 $73.8M $203.4M $1.77 $0.40 $1.37
02/12/2025 Q4 $73.5M $201.3M -$2.08 $0.38 -$2.46
11/06/2024 Q3 $73.8M $198.6M $1.39 $0.38 $1.01
08/07/2024 Q2 $71.3M $177.4M $0.41 $0.35 $0.06
05/09/2024 Q1 $72M $193M $1.36 $0.48 $0.88
02/14/2024 Q4 $78.9M $191.8M $0.16 $0.50 -$0.35
11/02/2023 Q3 -- $202.4M -$0.22 -- --
08/03/2023 Q2 -- $172M $0.23 -- --
05/04/2023 Q1 -- $152.8M $0.50 -- --
02/15/2023 Q4 -- $144.9M $1.02 -- --
11/03/2022 Q3 -- $150.8M -$2.65 -- --
08/04/2022 Q2 -- $196.3M -$2.29 -- --
05/05/2022 Q1 -- $202.2M -$3.56 -- --
02/17/2022 Q4 -- $221.2M -$0.01 -- --
11/03/2021 Q3 -- $220.6M $3.91 -- --
08/04/2021 Q2 -- $260.2M $1.80 -- --
05/05/2021 Q1 -- $280.9M $1.60 -- --
02/10/2021 Q4 -- $235.8M $1.68 -- --
11/04/2020 Q3 -- $312.9M $3.94 -- --
08/05/2020 Q2 -- $272.3M -$1.10 -- --
05/06/2020 Q1 -- -$128.9M -$6.24 -- --
02/12/2020 Q4 -- $352.7M $1.78 -- --
10/30/2019 Q3 -- $163.4M $1.40 -- --
07/31/2019 Q2 -- $227.5M $0.64 -- --
05/01/2019 Q1 -- $243.7M $1.61 -- --
02/13/2019 Q4 -- $353M -$1.88 -- --
10/31/2018 Q3 -- $318.5M $2.36 -- --
08/01/2018 Q2 -- $307.2M $1.74 -- --
05/03/2018 Q1 -- $310.2M $3.66 -- --
02/14/2018 Q4 -- $304.4M $1.56 -- --
11/02/2017 Q3 -- $289M $2.07 -- --
08/02/2017 Q2 -- $265.6M $1.68 -- --
05/01/2017 Q1 -- $247.2M $2.52 -- --
02/14/2017 Q4 -- $286M $3.48 -- --
11/01/2016 Q3 -- $239.8M $2.76 -- --
08/04/2016 Q2 -- $157.9M $1.17 -- --
05/02/2016 Q1 -- $258.1M $1.32 -- --
02/17/2016 Q4 -- $233.9M $1.80 -- --

Chimera Investment Corp. Earnings Questions

  • How Much did Chimera Investment Corp. Generate in Revenue Last Quarter?

    Chimera Investment Corp. reported $229.8M worth of top line sales in its most recent quarter.

  • Did Chimera Investment Corp. Beat Earnings Last Quarter?

    Chimera Investment Corp. announced earnings per share of -$0.27 which represents a miss of analyst forecast a $0.46 per share.

  • Is Chimera Investment Corp. Profitable?

    Chimera Investment Corp. reported $211.9M that represents $2.60 per share over the last quarter.

  • What is the Analyst Consensus for Chimera Investment Corp. EPS Next Year?

    Chimera Investment Corp.'s earnings are forecast to grow from $1.10 per share to $1.49 per share next year representing an increase of 60.06%.

  • When is Chimera Investment Corp.'s Earnings Date?

    Chimera Investment Corp.'s next earnings date is February 11, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock